Ovid Therapeutics (OVID) Stock Chart & Stock Price History → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free OVID Stock Alerts $3.15 +0.10 (+3.28%) (As of 12:53 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Ovid Therapeutics Stock Price Performance5 Day Performance-1.56%1 Month Performance-8.16%3 Month Performance-5.83%6 Month Performance-16.45%Year-To-Date Performance-2.17%1 Year Performance+10.53% Receive OVID Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Ovid Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Gold Safe ExchangeTrump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… OVID Stock Chart for Thursday, March, 28, 2024 OVID Chart by TradingView Ovid Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization03/27/2024$3.00$3.05+1.67%$3.12$3.00169,934 shs$215.67 million03/26/2024$3.09$3.00-2.91%$3.22$3.00239,291 shs$212.13 million03/25/2024$3.20$3.09-3.44%$3.27$3.05170,865 shs$218.49 million03/22/2024$3.05$3.20+4.92%$3.38$3.06439,443 shs$226.27 million03/21/2024$2.79$3.05+9.32%$3.22$2.95440,241 shs$215.67 million03/20/2024$2.75$2.79+1.45%$2.87$2.602.59 million shs$197.28 million Get the Latest News and Ratings for OVID and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ovid Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 03/19/2024$2.73$2.75+0.73%$2.80$2.70290,842 shs$194.45 million03/18/2024$2.72$2.73+0.37%$2.78$2.69272,979 shs$193.04 million03/15/2024$2.75$2.72-1.09%$2.97$2.64546,936 shs$192.33 million03/14/2024$2.82$2.75-2.48%$2.89$2.71165,290 shs$194.45 million03/13/2024$2.83$2.82-0.35%$2.86$2.73202,557 shs$199.40 million03/12/2024$2.94$2.83-3.74%$3.04$2.80172,789 shs$200.02 million03/11/2024$3.08$2.94-4.55%$3.10$2.9294,929 shs$207.80 million03/08/2024$3.17$3.08-2.84%$3.23$3.0795,778 shs$217.69 million03/07/2024$3.25$3.17-2.46%$3.39$3.1561,028 shs$224.06 million03/06/2024$3.27$3.25-0.61%$3.31$3.2155,583 shs$229.71 million03/05/2024$3.34$3.27-2.10%$3.36$3.23100,999 shs$231.12 million03/04/2024$3.40$3.34-1.76%$3.39$3.2671,272 shs$236.07 million03/01/2024$3.40$3.40$3.45$3.31116,003 shs$240.31 million02/29/2024$3.43$3.40-0.87%$3.52$3.30300,942 shs$240.31 million02/28/2024$3.63$3.43-5.51%$3.64$3.42537,905 shs$242.43 million02/27/2024$3.68$3.63-1.36%$3.77$3.5788,644 shs$256.57 million02/26/2024$3.70$3.68-0.54%$3.79$3.6862,501 shs$260.11 million02/23/2024$3.68$3.70+0.54%$3.75$3.66145,497 shs$261.52 million02/22/2024$3.57$3.68+3.08%$3.77$3.62227,122 shs$260.10 million02/21/2024$3.72$3.57-4.03%$3.70$3.5352,251 shs$252.33 million02/20/2024$3.84$3.72-3.12%$3.85$3.6384,537 shs$262.93 million02/19/2024$3.84$3.84$3.93$3.64133,600 shs$271.41 million02/16/2024$3.64$3.84+5.49%$3.93$3.64133,648 shs$271.41 million02/15/2024$3.77$3.64-3.45%$3.91$3.59312,379 shs$257.28 million02/14/2024$3.61$3.77+4.58%$3.80$3.6389,644 shs$266.46 million02/13/2024$4.04$3.61-10.77%$4.03$3.57161,145 shs$254.80 million02/12/2024$3.87$4.04+4.39%$4.10$3.86190,722 shs$285.55 million02/09/2024$3.75$3.87+3.20%$3.94$3.70284,849 shs$273.53 million02/08/2024$3.65$3.75+2.74%$3.80$3.58134,631 shs$265.05 million02/07/2024$3.70$3.65-1.35%$3.79$3.6080,594 shs$257.98 million02/06/2024$3.61$3.70+2.49%$3.77$3.5199,891 shs$261.52 million02/05/2024$3.70$3.61-2.43%$3.68$3.6066,319 shs$255.16 million02/02/2024$3.87$3.70-4.39%$3.93$3.7079,623 shs$261.52 million02/01/2024$3.87$3.87$3.93$3.77143,597 shs$273.53 millionTrump’s “Tax Free” Retirement Strategy (Ad)Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar…01/31/2024$3.93$3.87-1.53%$4.09$3.87292,228 shs$273.53 million01/30/2024$3.84$3.93+2.34%$3.98$3.76118,013 shs$277.77 million01/29/2024$3.72$3.84+3.23%$3.87$3.69167,558 shs$271.41 million01/26/2024$3.60$3.72+3.33%$3.72$3.6090,466 shs$262.93 million01/25/2024$3.54$3.60+1.69%$3.71$3.58208,496 shs$254.45 million01/24/2024$3.40$3.54+4.12%$3.67$3.20161,991 shs$250.21 million01/23/2024$3.29$3.40+3.34%$3.45$3.26308,182 shs$240.31 million01/22/2024$3.14$3.29+4.78%$3.31$3.13118,268 shs$232.54 million01/19/2024$3.14$3.14$3.17$3.0986,771 shs$221.94 million01/18/2024$3.10$3.14+1.29%$3.26$3.0769,001 shs$221.94 million01/17/2024$3.07$3.10+0.98%$3.11$3.04124,014 shs$219.11 million01/16/2024$3.13$3.07-1.92%$3.10$3.06117,009 shs$216.99 million01/15/2024$3.13$3.13$3.24$3.1064,300 shs$221.23 million01/12/2024$3.13$3.13$3.24$3.1064,380 shs$221.23 million01/11/2024$3.09$3.13+1.29%$3.16$3.04309,517 shs$221.23 million01/10/2024$3.10$3.09-0.32%$3.12$3.05194,785 shs$218.40 million01/09/2024$3.19$3.10-2.82%$3.16$3.07100,578 shs$219.11 million01/08/2024$3.05$3.19+4.59%$3.19$3.0357,522 shs$225.47 million01/05/2024$3.16$3.05-3.48%$3.17$3.0399,062 shs$215.57 million01/04/2024$3.16$3.16$3.23$3.12177,690 shs$223.35 million01/03/2024$3.32$3.16-4.82%$3.37$3.11199,711 shs$223.35 million01/02/2024$3.22$3.32+3.11%$3.34$3.20126,289 shs$234.66 million01/01/2024$3.22$3.22$3.39$3.20123,800 shs$227.59 million12/29/2023$3.35$3.22-3.74%$3.39$3.20123,842 shs$227.59 million12/28/2023$3.40$3.35-1.62%$3.44$3.33101,608 shs$236.43 million12/27/2023$3.39$3.40+0.29%$3.44$3.35140,045 shs$240.31 million Related Companies: ATOS Stock Price Chart OPTN Stock Price Chart SCPH Stock Price Chart GBIO Stock Price Chart AMLX Stock Price Chart GLYC Stock Price Chart VRCA Stock Price Chart ABEO Stock Price Chart PRQR Stock Price Chart PBYI Stock Price Chart Receive OVID Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Ovid Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:OVID) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceFed launches fourth dollar overhaulStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ovid Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.